Cite
MLA Citation
Reinhard Dummer et al.. “432 3-year results of the phase 2 randomized trial for talimogene laherparepvec (T-VEC) neoadjuvant treatment plus surgery vs surgery in patients with resectable stage IIIB-IVM1a melanoma.” Journal for immunotherapy of cancer, vol. 8, n.d., p. A458. http://access.bl.uk/ark:/81055/vdc_100144728682.0x000003